The Impact of Magnesium Supplementation on Insulin Resistance and Secretion in Renal Transplant Recipients
NCT01291030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2017-01-18
Summary
Hypomagnesemia is common in renal transplant recipients and is mainly because of enhanced renal magnesium wasting, caused by immunosuppressive drugs (calcineurin inhibitors). Glucose metabolism disorders, including insulin resistance and decreased insulin secretion, are also prevalent post-transplantation and often precede the development of diabetes. As magnesium supplementation has been demonstrated to increase insulin sensitivity in both diabetic and non-diabetic patients, its potential therapeutic supplementation (post-transplantation) deserves further examination. The hypothesis is that magnesium supplementation in renal transplant recipients exerts a beneficial effect on insulin resistance and/or secretion.
Conditions
- Glucose Metabolism
- Renal Transplantation
Interventions
- DIETARY_SUPPLEMENT
-
magnesium supplementation
The supplementation starts with 450 mg of magnesium oxide daily, up to a maximum of 3 times 450 mg daily, while aiming at a serum magnesium level of \> 1,9 mg/dl.
Sponsors & Collaborators
-
Astellas Pharma Inc
collaborator INDUSTRY -
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Steven Van Laecke, MD · University Hospital, Ghent
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
The Role of Biomarkers in the Early Detection of Acute Kidney Injury Induced by Liver Transplantation
NCT01333319 ·Status: COMPLETED
-
Short- and Long-Term Renal Outcomes Following Lung Transplantation
NCT03046277 ·Status: COMPLETED
-
Effects of Proton Pump Inhibitors on Kidney Transplant Recipients
NCT03123796 ·Status: COMPLETED
-
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation
NCT03866421 ·Status: TERMINATED
-
Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients
NCT00547040 ·Status: COMPLETED
-
The Study of Long-term Deterioration of Kidney Transplants.
NCT00217126 ·Status: COMPLETED
-
Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients
NCT00221533 ·Status: COMPLETED
-
Dietary Interventions During Living Kidney Donations
NCT05709600 ·Status: RECRUITING ·Phase: NA
-
Renal Outcomes Among Post Liver Transplantation Patients
NCT06123260 ·Status: NOT_YET_RECRUITING
-
Immunosuppressive Regimen on Changes in Renal Function and Transplant Rejection Rate in Patients With Lung Transplant
NCT03657004 ·Status: COMPLETED
-
Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients
NCT02233491 ·Status: COMPLETED ·Phase: NA
-
Resistive Index Measurements After Kidney Transplantation
NCT01879124 ·Status: COMPLETED
-
Measuring Kidney Function in Kidney Transplantation
NCT00212979 ·Status: COMPLETED
-
TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN)
NCT02811835 ·Status: ACTIVE_NOT_RECRUITING
-
Modification of Diet in Renal Transplantation (MDRT)
NCT03612778 ·Status: UNKNOWN ·Phase: NA
-
Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls
NCT00618761 ·Status: UNKNOWN ·Phase: NA
-
Association of the Intrarenal Resistance Index (RI) of Transplanted Kidneys With Generalized Atherosclerosis
NCT01001065 ·Status: UNKNOWN
-
Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
NCT05866796 ·Status: RECRUITING
-
A Study of Novel Biomarkers of Kidney Dysfunction at Liver Transplant
NCT03376009 ·Status: COMPLETED
-
Study on Delayed Graft Function Using Paired Kidneys
NCT01561599 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Renal Perfusion in Healthy Volunteers and Renal Transplant Recipients During an Orthostatic Stress
NCT02179411 ·Status: COMPLETED ·Phase: NA
-
Post Operative Hyponatremia in the Renal Transplant Population
NCT01456832 ·Status: COMPLETED
-
Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation
NCT00110656 ·Status: COMPLETED
-
TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study
NCT03272854 ·Status: ACTIVE_NOT_RECRUITING
-
Mesenchymal Stem Cells After Renal or Liver Transplantation
NCT01429038 ·Status: COMPLETED ·Phase: PHASE1/PHASE2